Case Definitions and Data Sources for NNCSS Parkinson Disease Surveillance: A Systematic Review - Report - MDSpire

Case Definitions and Data Sources for NNCSS Parkinson Disease Surveillance: A Systematic Review

  • By

  • Christine D. Esper

  • Kelly N. Hogan

  • Purni Abeysekara

  • Kasey Nichole Smith

  • Tenbroeck G. Smith

  • Shawna L. Mercer

  • June 8, 2026

  • 0 min

Share

Clinical Report: Systematic Review of Case Definitions for Parkinson Disease

Overview

This systematic review evaluates case definitions and data sources for Parkinson disease (PD) surveillance within the National Neurological Conditions Surveillance System (NNCSS). The findings highlight the importance of accurate case definitions to improve PD prevalence estimates and inform public health strategies.

Background

Parkinson disease is a prevalent neurodegenerative disorder that significantly impacts patients and healthcare systems. Accurate diagnosis is challenging due to overlapping clinical features with other parkinsonisms, leading to potential misdiagnosis. Establishing robust surveillance systems is crucial for understanding PD's burden and guiding research and treatment efforts.

Data Highlights

No numerical data or trial data presented in the article.

Key Findings

  • Systematic evaluation of case definitions is essential for effective PD surveillance.
  • Misclassification risk from overlapping conditions can skew PD prevalence estimates.
  • The NNCSS aims to enhance situational awareness for PD through comprehensive data aggregation.
  • Key attributes for public health surveillance systems include accuracy, simplicity, and cost-effectiveness.
  • Iterative processes were employed to assess and select optimal case definitions for PD.

Clinical Implications

Healthcare professionals should be aware of the complexities in diagnosing Parkinson disease and the potential for misclassification. Utilizing standardized case definitions can enhance the accuracy of PD surveillance and inform better patient care and resource allocation.

Conclusion

The systematic review underscores the critical need for precise case definitions in Parkinson disease surveillance to improve public health outcomes and research initiatives.

Related Resources & Content

  1. CDC, National Neurological Conditions Surveillance System, 2023 -- NNCSS Overview
  2. Global Burden of Disease Study, ScienceDirect, 2021 -- Burden of Parkinson's Disease
  3. Drugs - Real World Outcomes, 2023 -- Financial Impact of Parkinson’s Disease
  4. Acta Neuropathologica — Assessing and Analyzing the Cognitive Effects of Coexisting Mixed Neurodegenerative Disorders
  5. Acta Neuropathologica — Criteria for Neuropathological Diagnosis of Progressive Supranuclear Palsy Established by the Rainwater Charitable Foundation
  6. npj Digital Medicine — Innovative Remote Evaluation of Motor and Cognitive Functions in Parkinson's Disease: Utilizing Large Datasets, Machine Learning, and Telehealth Solutions
  7. National Neurological Conditions Surveillance System | NNCSS | CDC
  8. Global, regional and national burden of Parkinson's disease, 1990–2021
  9. Efficacy and safety of intravenous prasinezumab in individuals with early-stage Parkinson's disease on stable symptomatic monotherapy (PADOVA): a phase 2b, multicentre, randomised, double-blind, placebo-controlled study - ScienceDirect

Original Source(s)

Related Content